ASARFIAsarfi Hospital Ltd.

₹143.45-5.28%

Market Cap

₹282.27 Cr

Stock P/E

26.69

ROCE

15.86%

ROE

13.97%

Book Value

₹42.74

Financials

YoY Net Sales

EPS Growth

Operating Margin

You might have missed

No Recent News

No recent news available for this stock.

Shareholding

Holdings

Distribution

Promoter

Foreign Investors

Domestic Investors

Public

From Last Concall

POSITIVES

•
Robust top-line growth and margin expansion in FY25.
•
Cancer hospital expansion with advanced technology and capacity to scale.

NEGATIVES

•
Significant working capital risk due to government receivables and delays in cash collections.
•
Cancer hospital occupancy is currently around 30% despite expansion plans; revenue drivers extend beyond bed occupancy.

Peers Summary

Sector Leader

Asarfi Hospital Ltd. shows respectable growth and profitability metrics, though it faces stiff competition from peers with higher efficiency and profitability ratios. Notably, it exhibits a strong revenue growth rate, making it a compelling choice in the hospital and healthcare services sector.

Key Points

• Asarfi Hospital Ltd. has the highest revenue growth (YoY) at 42.85%.
• Max Healthcare has the highest ROE at 13.47%.
• Aster DM Healthcare has the lowest PE ratio at 5.05, indicating potential undervaluation.
• Apollo Hospitals has the highest EPS at 100.56, showcasing strong earnings performance.
• Fortis Healthcare is financially stressed with a very high PE ratio of 1094.63.

Top Performers

Max Healthcare Institute Ltd.

Highest ROE and strong revenue growth, indicating efficient use of equity and solid performance.

Apollo Hospitals Enterprise Ltd.

Highest EPS and good profitability metrics, showcasing strong earnings power.

Asarfi Hospital Ltd.

Best revenue growth rate, indicating strong expansion potential.

Explore

Watchlists

Command Palette